Key result
Discrimination between Type 1 and Type 2 myocardial infarction in critically ill patients with elevated troponin is challenging but paramount for appropriate treatment.
Case Report
Highlights the diagnostic challenge and importance of distinguishing Type 1 from Type 2 myocardial infarction in critically ill patients with elevated troponin to provide appropriate treatment.
Differentiating Type 1 from Type 2 MI in critically ill patients requires careful evaluation; case reports leave standardized approaches open for prospective research.
A common problem in the intensive care unit is interpreting elevated cardiac biomarkers in patients hospitalized for serious non-cardiac diseases. The following case example demonstrates the importance of the clinical context when interpreting the cardiac biomarkers in critically ill patients. Elevated cTn in critically ill patient should be investigated thoroughly and distinction between Type1 myocardial infarction from Type 2 is established. There are numerous causes of troponin release due to myocardial damage, while some are related to myocardial ischemia others are not. Discrimination of Type 2 MI from Type 1 MI and troponin release due to non-coronary diseases is challenging. However, discrimination is paramount in order to provide timely and appropriate treatment.
No takes yet. Share an insight, caveat, or question.
Moussa et al. (2011) conducted a case report in Elevated cardiac biomarkers in critically ill patients. Discrimination between Type 1 and Type 2 myocardial infarction in critically ill patients with elevated troponin is challenging but paramount for appropriate treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: